Skip to main content

Table 2 Description of acute skin toxicity in the population of study, stratified for each grade, according to RTOG scale and clinical results

From: Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments

Grade

Skin toxicity description

Number of cases

% of cases

Grade 0

No change over baseline

20/50

40%

Grade 1

Follicular, faint or dull erythema/ epilation/dry desquamation/ decreased sweating

32/50

64%

Grade 2

Tender or bright erythema, patchy moist desquamation/ moderate edema

0/50

0%

Grade 3

Confluent, moist desquamatiom other than skin folds, pitting edema

1/50

2%

Grade 4

Ulceration, hemorrhage, necrosis

0/50

0%